Madrigal Pharmaceuticals (MDGL) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 86.03% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 18.44% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 37.21% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 36.73% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | -38.31% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 67.51% |
| 10 | Madrigal Pharmaceuticals | 15.76 Bn | 14.92 Bn | - | 25.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.20% |
| Mar 31, 2026 | 9.07% |
| Dec 31, 2025 | 19.60% |
| Sep 30, 2025 | -1.35% |
| Jun 30, 2025 | 22.79% |
| Mar 31, 2025 | 0.47% |
| Dec 31, 2024 | 10.56% |
| Sep 30, 2024 | -9.06% |
| Jun 30, 2024 | -24.04% |
| Mar 31, 2024 | -30.30% |
| Dec 31, 2023 | -16.19% |
| Sep 30, 2023 | -12.51% |
| Jun 30, 2023 | -13.76% |
| Mar 31, 2023 | -21.76% |
| Dec 31, 2022 | -40.64% |
| Sep 30, 2022 | -50.59% |
| Jun 30, 2022 | -47.77% |
| Mar 31, 2022 | -50.76% |
| Dec 31, 2021 | -71.38% |
| Sep 30, 2021 | -89.64% |